» Articles » PMID: 37227280

Systematic Microbiome Dysbiosis Is Associated with IgA Nephropathy

Overview
Specialty Microbiology
Date 2023 May 25
PMID 37227280
Authors
Affiliations
Soon will be listed here.
Abstract

IgA nephropathy (IgAN) is reportedly associated with microbial dysbiosis. However, the microbiome dysregulation of IgAN patients across multiple niches remains unclear. To gain a systematic understanding of microbial dysbiosis, we conducted large-scale 16S rRNA gene sequencing in IgAN patients and healthy volunteers across 1,732 oral, pharynx, gut, and urine samples. We observed a niche-specific increase of several opportunistic pathogens, including and in the oral and pharynx, whereas some beneficial commensals decreased in IgAN patients. Similar alterations were also observed in the early versus advanced stage of chronic kidney disease (CKD) progression. Moreover, , and in the oral and pharynx were positively associated with creatinine and urea, indicating renal lesions. Random forest classifiers were developed by using the microbial abundance to predict IgAN, achieving an optimal accuracy of 0.879 in the discovery phase and 0.780 in the validation phase. This study provides microbial profiles of IgAN across multiple niches and underlines the potential of these biomarkers as promising, noninvasive tools with which to differentiate IgAN patients for clinical applications.

Citing Articles

Single-Cell RNA-Sequencing Analysis Provides Insights into IgA Nephropathy.

Xia M, Li Y, Liu Y, Dong Z, Liu H Biomolecules. 2025; 15(2).

PMID: 40001494 PMC: 11853383. DOI: 10.3390/biom15020191.


The evolving understanding of systemic mechanisms in organ-specific IgA nephropathy: a focus on gut-kidney crosstalk.

Wang X, Zhou X, Qiao X, Falchi M, Liu J, Zhang H Theranostics. 2025; 15(2):656-681.

PMID: 39744688 PMC: 11671385. DOI: 10.7150/thno.104631.


What is new in the pathogenesis and treatment of IgA glomerulonephritis.

Salvadori M, Rosso G World J Nephrol. 2024; 13(4):98709.

PMID: 39723359 PMC: 11572654. DOI: 10.5527/wjn.v13.i4.98709.


Machine learning-based diagnosis and prognosis of IgAN: A systematic review and meta-analysis.

Zhuang K, Wang W, Xu C, Guo X, Ren X, Liang Y Heliyon. 2024; 10(12):e33090.

PMID: 38988582 PMC: 11234108. DOI: 10.1016/j.heliyon.2024.e33090.

References
1.
Ren Z, Fan Y, Li A, Shen Q, Wu J, Ren L . Alterations of the Human Gut Microbiome in Chronic Kidney Disease. Adv Sci (Weinh). 2020; 7(20):2001936. PMC: 7578882. DOI: 10.1002/advs.202001936. View

2.
He J, Zhou X, Lv J, Zhang H . Perspectives on how mucosal immune responses, infections and gut microbiome shape IgA nephropathy and future therapies. Theranostics. 2020; 10(25):11462-11478. PMC: 7545987. DOI: 10.7150/thno.49778. View

3.
Mallick H, Rahnavard A, McIver L, Ma S, Zhang Y, Nguyen L . Multivariable association discovery in population-scale meta-omics studies. PLoS Comput Biol. 2021; 17(11):e1009442. PMC: 8714082. DOI: 10.1371/journal.pcbi.1009442. View

4.
DAmico G . Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol. 2004; 24(3):179-96. DOI: 10.1016/j.semnephrol.2004.01.001. View

5.
Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F . A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012; 490(7418):55-60. DOI: 10.1038/nature11450. View